DECODERX
LIVE

Serial Number

98672584

Owner

Precision Medicine Group, LLC

Attorney

Donna H. Hartman

First Use Date

Nov 22, 2024

Filing Date

Jul 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DECODERX Trademark

Serial Number: 98672584

DECODERX is a trademark filed by Precision Medicine Group, LLC on July 29, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Precision Medicine Group, LLC

2 Bethesda Metro Center, Suite 850
Bethesda, MD 20814

Entity Type: 16

Trademark Details

Filing Date

July 29, 2024

Registration Date

Not Registered

First Use Anywhere

November 22, 2024

First Use in Commerce

November 22, 2024

Published for Opposition

May 6, 2025

Goods & Services

Providing an internet website portal in the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries that features technology for data mastering files and bulk file transfer; Application service provider featuring application programming interface (API) software for connecting a variety of payer and provider datasets in the in the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries; Providing an on-line network environment that features technology that enables users in the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries to share data.

Downloadable computer software for use as an application programming interface (API) for data mastering files and bulk file transfer to connect payer and provider datasets to the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries.

Providing business management consulting services, namely, advice and business strategies for payer and provider access decision making to healthcare, pharmaceutical, medical biotechnology, and life sciences companies in the fields of launch planning, access strategy, data orchestration, predictive analytics, product uptake forecasting, promotional focus, and market adoption; Providing business management consultation services in the fields of market access, market access analytics, commercial operations, promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy, and distribution strategy to the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries.

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 18, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 18, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 29, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 29, 2026 AITU
USE AMENDMENT FILED
Jul 23, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 23, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 14, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
NEW APPLICATION ENTERED
Jul 30, 2024 NWAP